English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 852140 Online Users : 1374
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
感染症與疫苗研究所
劉士任
--專利
--期刊論文
--圖書
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
感染症與疫苗研究所
>
劉士任
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
專利
[
0
/24]
期刊論文
[
110
/113]
圖書
[
1
/1]
會議論文/會議摘要
[
10
/11]
Siblings
余佳益
[
17
/17]
余冠儀
[
40
/40]
冷治湘
[
61
/89]
劉家齊
[
45
/52]
司徒惠康
[
71
/72]
吳綺容
[
84
/84]
周彥宏
[
46
/58]
宋旺洲
[
33
/34]
廖經倫
[
32
/32]
張仲明
[
2
/2]
張堯
[
44
/44]
曾凡真
[
34
/34]
曾才騰
[
9
/9]
李敏西
[
60
/64]
杜鴻運
[
50
/50]
楊采菱
[
133
/134]
潘建雄
[
18
/19]
羅秀容
[
96
/97]
胡勇誌
[
23
/23]
莊再成
[
104
/153]
蕭樑基
[
158
/161]
蘇益仁(2002-2015)
[
190
/195]
許修誌(2005-2010)
[
1
/1]
許素菁
[
27
/30]
謝鐸源(2006-2014)
[
20
/27]
郭書辰
[
139
/141]
陳俊宏
[
61
/62]
陳信偉
[
83
/110]
陳宜君
[
38
/38]
陳逢叡
[
40
/40]
黃明熙
[
51
/64]
黃盈綺
[
6
/6]
齊嘉鈺
[
46
/46]
McDonald LC(1998-2000)
[
12
/12]
何曼德(1997-2002)
[
38
/39]
其他
[
177
/177]
朱清良(2005-2007)
[
4
/4]
梁蘭蘭(1998-2006)
[
6
/6]
黃崑巖(1999-2004)
[
4
/4]
Community Statistics
近3年內發表的文件:19(12.75%)
含全文筆數:121(81.21%)
文件下載次數統計
下載大於0次:121(100.00%)
下載大於100次:115(95.04%)
檔案下載總次數:67278(1.26%)
最後更新時間: 2024-11-28 09:35
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Boosting DNA vaccine power by lipid...
ADAM9 drives the immunosuppressive ...
Inhibition of ADAM9 promotes the se...
Lipid nanoparticle-encapsulated DNA...
ADAM9 drives immunosuppressive envi...
A broad-spectrum pneumococcal vacci...
Co-delivery of a trimeric spike DNA...
A TLR9 agonist synergistically enha...
TLR9 and STING agonists cooperative...
Recombinant lipidated FLIPr effecti...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 51-100 of 149. (3 Page(s) Totally)
<<
<
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2016-12
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer
Oncotarget. 2016 Dec;7(52):85917-85928.
2016-11-09
Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy
Scientific Reports. 2016 Nov 09;6:Article number 36732.
2016-07-29
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
Scientific Reports. 2016 Jul 29;6:Article number 30648.
2016-07
Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice
Cancer Letters. 2016 Jul;377(2):126-133.
2016-06
TGF-beta and IL-21 cooperatively stimulate activated CD8 T cells to differentiate into Tc17 cells
Immunology Letters. 2016 Jun;174:23-27.
2016-05-06
A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity
Journal of Controlled Release. 2016 May 6;233:57-63.
2016-05
A toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population
Oncotarget. 2016 May;7(21):30804-30819.
2016-04
Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunity
Scientific Reports. 2016 Apr;6:Article number 24199.
2016-02
Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
Vaccine. 2016 Feb;34(8):1054-1061.
2016-01
A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model
Oncotarget. 2016 Jan;7(1):671-683.
2015-12
Recombinant bacterial lipoproteins as vaccine candidates
Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.
2015-11
Gemcitabine synergistically enhances anti-tumor effects of recombinant immunogen-based cancer immunotherapy
Annals of Oncology. 2015 Nov;26(Suppl. 7):vii79-vii105.
2015-10
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy
OncoImmunology. 2015 Oct 29;5(3):e1095433.
2015-08-07
Recombinant lipoprotein-based vaccine candidates against C. difficile infections
Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
2015-07-28
A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms
Scientific Reports. 2015 Jul 28;5:Article number 12578.
2015-06
Recombinant lipoproteins as novel vaccines with intrinsic adjuvant
Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2015-05-11
佐劑
I483735/2015-05-11
2015-03-06
脂質化腫瘤相關抗原及其免疫治療的組成物及方法
HK1171457/2015-03-06
2015-03
Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: Potential clinical impact
Expert Review of Vaccines. 2015 Mar;14(3):383-394.
2015-02
漫談預防型和治療型子宮頸癌疫苗的現況與未來
院內感染控制雜誌. 2015 Feb;25(1):31-36.
2014-11
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide
Human Vaccines and Immunotherapeutics. 2014 Nov;10(11):3241-3250.
2014-10-29
脂质化肿瘤相关抗原及其免疫治疗的组成物及方法
ZL201080027969.8/2014-10-29
2014-10
Chemotherapy enhances recombinant lipoimmunogen-based antitumor immunity against cervical cancer
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 637.
2014-08-27
Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice
BioMed Research International. 2014 Aug 27;2014:Article number 878139.
2014-07-30
Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns
Journal of Virology. 2014 Jul 30;88(20):11658-11670.
2014-07-08
Method of producing lipidated polypeptides
US8771990B2/2014-07-08
2014-07
Depletion of tumor-associated macrophages enhances peptide-based cancer immunotherapy
European Journal of Cancer. 2014 Jul;50(Suppl. 5):S215.
2014-06-11
Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems
Biomed Research International. 2014 Jun 11;2014:Article number 670506.
2014-05
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells
Journal of Immunology. 2014 May;192(9):4233-4241.
2014-04-23
Lipidated tumor-associated antigens and immunotherapeutic compositions
EP2445927/2014-04-23
2014-03-19
Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
Molecular Cancer. 2014 Mar 19;13:Article number 60.
2014-03
Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
Vaccine. 2014 Mar;32(12):1346-1353.
2014-03
A purified recombinant lipopeptide as adjuvant for cancer immunotherapy
BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-02-25
Lipidated tumor-associated antigens and immunotherapeutic compositions
US8658176B2/2014-02-25
2014-02-25
Lipidated polyepitope vaccines
US8658767B2/2014-02-25
2014-01
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity
Journal of Controlled Release. 2014 Jan;173(1):158-165.
2014-01
Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide
Biomaterials. 2014 Jan;35(5):1686-1695.
2013-12
Increased IL-8 and IL-1beta in the bile of acute cholecystitis patients
BioMedicine. 2013 Dec;3(4):181-185.
2013-09-21
脂質化腫瘤相關抗原及其免疫治療的組成物及方法
I409275/2013-09-21
2013-09-19
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement
PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09
Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III
Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07
A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
Archives of Virology. 2013 Jul;158(7):1523-1531.
2013-06-18
Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy
US8465756B2/2013-06-18
2013-06-18
Adjuvants
US8466259B2/2013-06-18
2013-06-13
Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence
ACS Medicinal Chemistry Letters. 2013 Jun 13;4(6):522-526.
2013-06-11
腫瘤相關抗原之免疫性肽類及其於癌症治療上的用途
I398262/2013-06-11
2013-05-21
Multi-phase emulsions based on amphiphilic block copolymers
US8444993B2/2013-05-21
2013-05
Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines
Journal of Immunology. 2013 May;190(10):5065-5077.
2013-04-23
Production of lipidated proteins in E. coli
US8426163B2/2013-04-23
2013-02-01
以兩性團聯共聚物為基礎的複合相乳狀液
I383806/2013-02-01
Showing items 51-100 of 149. (3 Page(s) Totally)
<<
<
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback